409 related articles for article (PubMed ID: 8202552)
1. Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith MA; Taneda S; Richey PL; Miyata S; Yan SD; Stern D; Sayre LM; Monnier VM; Perry G
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5710-4. PubMed ID: 8202552
[TBL] [Abstract][Full Text] [Related]
2. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
3. The Maillard reaction and food allergies: is there a link?
Toda M; Heilmann M; Ilchmann A; Vieths S
Clin Chem Lab Med; 2014 Jan; 52(1):61-7. PubMed ID: 23492561
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation modification of Rosenthal fibers in patients with Alexander disease.
Castellani RJ; Perry G; Harris PL; Monnier VM; Cohen ML; Smith MA
Neurosci Lett; 1997 Aug; 231(2):79-82. PubMed ID: 9291145
[TBL] [Abstract][Full Text] [Related]
5. Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains.
Kimura T; Takamatsu J; Miyata T; Miyakawa T; Horiuchi S
Pathol Int; 1998 Aug; 48(8):575-9. PubMed ID: 9736403
[TBL] [Abstract][Full Text] [Related]
6. Lipoperoxidation is selectively involved in progressive supranuclear palsy.
Odetti P; Garibaldi S; Norese R; Angelini G; Marinelli L; Valentini S; Menini S; Traverso N; Zaccheo D; Siedlak S; Perry G; Smith MA; Tabaton M
J Neuropathol Exp Neurol; 2000 May; 59(5):393-7. PubMed ID: 10888369
[TBL] [Abstract][Full Text] [Related]
7. Review of pentosidine and pyrraline in food and chemical models: formation, potential risks and determination.
Li H; Yu SJ
J Sci Food Agric; 2018 Jul; 98(9):3225-3233. PubMed ID: 29280151
[TBL] [Abstract][Full Text] [Related]
8. Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation.
Smith PR; Somani HH; Thornalley PJ; Benn J; Sonksen PH
Clin Sci (Lond); 1993 Jan; 84(1):87-93. PubMed ID: 8382140
[TBL] [Abstract][Full Text] [Related]
9. Structure of advanced Maillard reaction products and their pathological role.
Monnier VM; Nagaraj RH; Portero-Otin M; Glomb M; Elgawish AH; Sell DR; Friedlander MA
Nephrol Dial Transplant; 1996; 11 Suppl 5():20-6. PubMed ID: 9044302
[TBL] [Abstract][Full Text] [Related]
10. Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes.
Nagaraj RH; Portero-Otin M; Monnier VM
Arch Biochem Biophys; 1996 Jan; 325(2):152-8. PubMed ID: 8561492
[TBL] [Abstract][Full Text] [Related]
11. Identification of advanced glycation end products of the Maillard reaction in Pick's disease.
Kimura T; Ikeda K; Takamatsu J; Miyata T; Sobue G; Miyakawa T; Horiuchi S
Neurosci Lett; 1996 Nov; 219(2):95-8. PubMed ID: 8971788
[TBL] [Abstract][Full Text] [Related]
12. Modification of vimentin: a general mechanism of nonenzymatic glycation in human skin.
Kueper T; Grune T; Muhr GM; Lenz H; Wittern KP; Wenck H; Stäb F; Blatt T
Ann N Y Acad Sci; 2008 Apr; 1126():328-32. PubMed ID: 18448838
[TBL] [Abstract][Full Text] [Related]
13. Pyrraline Formation Modulated by Sodium Chloride and Controlled by Encapsulation with Different Coating Materials in the Maillard Reaction.
Liang Z; Chen X; Yang Z; Lai Y; Yang Y; Lei C; Zeng Y
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31717655
[TBL] [Abstract][Full Text] [Related]
14. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
[TBL] [Abstract][Full Text] [Related]
15. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.
Castellani RJ; Harris PL; Sayre LM; Fujii J; Taniguchi N; Vitek MP; Founds H; Atwood CS; Perry G; Smith MA
Free Radic Biol Med; 2001 Jul; 31(2):175-80. PubMed ID: 11440829
[TBL] [Abstract][Full Text] [Related]
16. The presence of a glucose-derived Maillard reaction product in the human lens.
Nagaraj RH; Sady C
FEBS Lett; 1996 Mar; 382(3):234-8. PubMed ID: 8605976
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
18. Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease.
Smith MA; Richey PL; Taneda S; Kutty RK; Sayre LM; Monnier VM; Perry G
Ann N Y Acad Sci; 1994 Nov; 738():447-54. PubMed ID: 7832455
[No Abstract] [Full Text] [Related]
19. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes.
Paul RG; Bailey AJ
Int J Biochem Cell Biol; 1996 Dec; 28(12):1297-310. PubMed ID: 9022289
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-products in diabetic nephropathy.
Sugiyama S; Miyata T; Horie K; Iida Y; Tsuyuki M; Tanaka H; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 5():91-4. PubMed ID: 9044316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
